Rupee falls 2 paise to 83.81 against US dollar in early trade (01-10-2024)
Rupee falls to 83.81 against the US dollar due to significant foreign fund outflows amid volatile global markets. Despite a stronger dollar, retreating crude oil prices and a recovery in domestic equities limited the decline. Chinese fiscal stimulus draws foreign investment away from India.
What to do with Policybazaar, Vedanta, IEX and 3 other stocks? Religare Broking’s Ravi Singh decodes (01-10-2024)
In October, focus on metals, infrastructure, and financial sectors. Hold Ceat, Vedanta, NALCO, Policybazaar, and IEX. Exit Easy Trip.
Kalpataru Projects share up over 3% on Rs 1,241-cr order win; details here (01-10-2024)
The Kalpataru Projects International share rose after the company announced that it has been awarded new orders worth Rs 1,241 crore.
Mahindra & Mahindra September sales volumes surge 16% (01-10-2024)
Sells 87,839 units
Indices edge higher in early trade; breadth strong (01-10-2024)
At 09:30 IST, the barometer index, the S&P BSE Sensex, was up 205.21 points or 0.24% to 84,504.99. The Nifty 50 index rose 41.50 points or 0.16% to 25,852.35.
Transaction charges on NSE, BSE, MCX, Higher STT from today: Things to know (01-10-2024)
From Tuesday onwards i.e effective October 1, 2024, the Indian financial markets will undergo several reforms that investors must know
Hot Stocks: Brokerage views on PB Fintech, Kaynes and Aadhar Housing (01-10-2024)
Jefferies has reiterated its buy rating on PB Fintech, setting a target price of Rs 1,800. The company’s management plans a one-time investment of up to $100 million for a 20-35% stake in a new healthcare venture, addressing concerns about maintaining its asset-light strategy. PB Fintech remains a top pick for India’s growing insurance market, with its core business continuing to experience strong growth.